Corrigendum to: Post-treatment neutrophil to lymphocyte ratio as a prognostic tool in patients treated with tocilizumab for severe COVID-19 pneumonia - a single center experience
Description
[This corrects the article DOI: 10.11613/BM.2023.020704.].
